Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.810
-0.390 (-17.73%)
At close: May 12, 2025, 4:00 PM
1.960
+0.150 (8.29%)
Pre-market: May 13, 2025, 4:37 AM EDT
APUS Market Cap
APUS has a market cap or net worth of $20.94 million as of May 12, 2025.
Market Cap
20.94M
Enterprise Value
21.61M
1-Year Change
n/a
Ranking
Category
Stock Price
1.81
Market Cap Chart
Since the IPO on May 8, 2025, APUS's market cap has decreased from $46.29M to $20.94M, a decrease of -54.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 25.46M | -45.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.56B |
| Johnson & Johnson | 371.89B |
| UnitedHealth Group | 342.90B |
| AbbVie | 337.79B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 230.35B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |